Categories
Business

Plasma Fractionation Market Sales Projections Forecast Positive Growth Through 2031 : FactMR

According to Fact.MR, the sales of plasma fractionation is expected to register a CAGR of more than 7% along with the market size being valued at US$ 38 Bn at the end of the 2021-2031 forecast period. Rising prevalence of infectious and chronic diseases is majorly spurring expansion of the market.

As per historical trends, between 2016 and 2020, demand for plasma fractionation surged at a CAGR of 5%, closing in at a valuation of US$ 19 Bn. The impact of COVID-19 has been tremendously huge on the plasma fractionation market. Increase in respiratory problems and blood disorders has led to patients opting for plasma fractionation. Technological advancements in the plasma fractionation sector has further propelled the growth of plasma fractionation.

Prominent manufacturers are expected to capitalize on the ever-growing prospects for treating neurological disorders. Statistics suggest that these disorders have affected 450 million globally. Thus, the neurology segment for plasma fractionation is expected to witness robust growth by registering a CAGR of 7.2%

For detailed insights on enhancing your product footprint, request a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4806

A detailed assessment of the plasma fractionation market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the plasma fractionation market along with their product portfolio enhances the reliability of this comprehensive research study.

“Burgeoning technological innovations, combined with widespread usage of immunoglobulins for treating various neurological and autoimmune diseases shall broaden growth prospects. A positive growth trajectory is predicted for the plasma fractionation market during the forecast period,” infers a Fact.MR analyst.

Prominent manufacturers with established market presence in global Plasma fractionation market are

  • GRIFOLS
  • Sanquin
  • CSL Behring Limited
  • Shire Plc.
  • Biotest AG
  • Baxter International

COVID-19 Analysis on the Global Plasma Fractionation Market

A recent market research report on the Plasma Fractionation market published by Fact.MR is an in-depth assessment of the current landscape of the market. Further, the report elaborates on the impact of the COVID-19 on the Plasma Fractionation market and provides a thorough understanding of the growth potential of each market segment over the forecast period (2020 to 2026).

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4806

Plasma Fractionation Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the plasma fractionation market across the globe.

A comprehensive estimate on the plasma fractionation market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of plasma fractionation market during the forecast period.

 Plasma Fractionation Market Segmentation

Fact.MR has studied the plasma fractionation market with detailed segmentation on the basis of product, application, end-user and region.

For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4806

Product Application End-user Region
Immunoglobulins: 

  • Intravenous Immunoglobulins
  • Subcutaneous Immunoglobulins
Neurology Hospitals & Clinics North America
Coagulation Factor Concentrates: 

  • Factor VIII
  • Factor IX
  • Factor XIII
  • Prothrombin Complex Concentrate
  • Von Willebrand Factor (VWF)
  • Fibrinogen Concentrates
Immunology Clinical Research Laboratories Europe
Albumin Hematology Academic Institutions Asia Pacific
Protease Inhibitors Critical Care Latin America
Other Plasma Products Pulmonary Middle East & Africa
Other Applications

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

For in-depth competitive analysis, buy now-  https://www.factmr.com/checkout/4806

Plasma Fractionation Market: Analysis on Market Size Evaluation

The plasma fractionation market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for Plasma fractionation market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent plasma fractionation market segments, along with market attractiveness evaluation has been incorporated in the report.

Plasma Fractionation Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the plasma fractionation report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the plasma fractionation market during the forecast period.

For More Insights:  https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract–glaucoma-treatment-factmr-301262063.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Global Plasma Fractionation Market To Record Significant Growth In Revenue During Forecast Period : FactMR

According to Fact.MR, the sales of plasma fractionation is expected to register a CAGR of more than 7% along with the market size being valued at US$ 38 Bn at the end of the 2021-2031 forecast period. Rising prevalence of infectious and chronic diseases is majorly spurring expansion of the market.

As per historical trends, between 2016 and 2020, demand for plasma fractionation surged at a CAGR of 5%, closing in at a valuation of US$ 19 Bn. The impact of COVID-19 has been tremendously huge on the plasma fractionation market. Increase in respiratory problems and blood disorders has led to patients opting for plasma fractionation. Technological advancements in the plasma fractionation sector has further propelled the growth of plasma fractionation.

Prominent manufacturers are expected to capitalize on the ever-growing prospects for treating neurological disorders. Statistics suggest that these disorders have affected 450 million globally. Thus, the neurology segment for plasma fractionation is expected to witness robust growth by registering a CAGR of 7.2%

For detailed insights on enhancing your product footprint, request a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4806

A detailed assessment of the plasma fractionation market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the plasma fractionation market along with their product portfolio enhances the reliability of this comprehensive research study.

“Burgeoning technological innovations, combined with widespread usage of immunoglobulins for treating various neurological and autoimmune diseases shall broaden growth prospects. A positive growth trajectory is predicted for the plasma fractionation market during the forecast period,” infers a Fact.MR analyst.

Prominent manufacturers with established market presence in global Plasma fractionation market are

  • GRIFOLS
  • Sanquin
  • CSL Behring Limited
  • Shire Plc.
  • Biotest AG
  • Baxter International

COVID-19 Analysis on the Global Plasma Fractionation Market

A recent market research report on the Plasma Fractionation market published by Fact.MR is an in-depth assessment of the current landscape of the market. Further, the report elaborates on the impact of the COVID-19 on the Plasma Fractionation market and provides a thorough understanding of the growth potential of each market segment over the forecast period (2020 to 2026).

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4806

Plasma Fractionation Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the plasma fractionation market across the globe.

A comprehensive estimate on the plasma fractionation market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of plasma fractionation market during the forecast period.

 Plasma Fractionation Market Segmentation

Fact.MR has studied the plasma fractionation market with detailed segmentation on the basis of product, application, end-user and region.

For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4806

Product Application End-user Region
Immunoglobulins: 

  • Intravenous Immunoglobulins
  • Subcutaneous Immunoglobulins
Neurology Hospitals & Clinics North America
Coagulation Factor Concentrates: 

  • Factor VIII
  • Factor IX
  • Factor XIII
  • Prothrombin Complex Concentrate
  • Von Willebrand Factor (VWF)
  • Fibrinogen Concentrates
Immunology Clinical Research Laboratories Europe
Albumin Hematology Academic Institutions Asia Pacific
Protease Inhibitors Critical Care Latin America
Other Plasma Products Pulmonary Middle East & Africa
Other Applications

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

For in-depth competitive analysis, buy now-  https://www.factmr.com/checkout/4806

Plasma Fractionation Market: Analysis on Market Size Evaluation

The plasma fractionation market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for Plasma fractionation market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent plasma fractionation market segments, along with market attractiveness evaluation has been incorporated in the report.

Plasma Fractionation Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the plasma fractionation report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the plasma fractionation market during the forecast period.

For More Insights:  https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract–glaucoma-treatment-factmr-301262063.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

How are Technological Advancements Anticipated to Fuel Plasma Fractionation Market Expansion Prospects

Fact.MR forecasts bullish prospects for the plasma fractionation market. The utilization of immunoglobulins has augmented in the last few years. Plasma-derived immunoglobulins are giving a new narrative to healthcare across a wide range of autoimmune and inflammatory diseases. This widespread applicability is anticipated to leverage market prospects for plasma fractionation, pegged to witness a noteworthy 7% CAGR

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4806

In addition, consistent technological innovations for developing efficient and cost-effective procedures for fractioning proteins shall also augment the plasma fractionation market. Therapies such as Ceruloplasmin and IgA are some examples of such innovations. Based on these trends, the plasma fractionation market is anticipated to scale up in the future, expanding 1.5x in the forecast period. (2020-2026)

Key Takeaways from the Plasma Fractionation Market Study:

  • By product, intravenous immunoglobulins are poised to maintain their hegemony in the plasma fractionation market. The segment is poised to capture more than 2/5th of the overall market. High incidence of autoimmune diseases shall drive growth within this segment.
  • By application, the neurology segment shall leverage almost 2.0x, capturing more than 2/5th of the plasma fractionation market. Rising prevalence of neurological disorders is attributed as an important growth driver for this segment. More than 450 million people worldwide are affected by neurological disorders.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4806

  • By end-user, hospitals and clinics shall account for a significant chunk of revenue, capturing nearly 70% of the plasma fractionation market. Robust expansion of hospitals as a result of significant investments is set to augment the share of this segment.
  • By region, North America shall dominate the plasma fractionation market. Rising prevalence of autoimmune, neurological and hemophilic diseases shall augment market prospects for the region. The North American market shall capture nearly 2/5th of the plasma fractionation market.
  • Following North America is the Asia-Pacific, expanding at a healthy CAGR of 8.0%. Prevalence of bleeding and immune disorders have prompted greater utilization of plasma fractionation techniques. Moreover, improving healthcare infrastructure and awareness about plasma fractionation proteins and their use are other growth levers.
  • The COVID-19 pandemic is set to generate significant growth opportunities for the plasma fractionation market. Convalescent Plasma (CP) treatment is anticipated to be a key development in this regard.
  • Key players such as Octapharma and Grifols are actively engaged in finding potential cures for the novel coronavirus diseases through the CP technique.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4806

Stakeholders’ Consensus on Novel Offerings to Herald an Era of Profitability

The plasma fractionation market consists of a host of market players. These include: CSL Behring, Shire plc, Sanquin, Biotest AG, GRIFOLS, Baxter International Inc., Kedrion, Octapharma USA Inc. to name a few. Innovative offerings are key growth strategies adopted by market players.

CSL Behring, for instance, markets the Privigen, Carimune, Snadoglobulin and Hizentra solutions. Sanquin produces four types of plasma products using various isolation techniques: coagulation factors, protease inhibitors, immunoglobulins and albumin. The company also offers contract fractionation services.

Biotest AG develops, manufactures and markets plasma proteins and biotherapeutic drugs. It leads in the field of plasma collection. Biotest AG presently develops plasma proteins for Primary Immune Deficiency (PID) and various hyperimmune products. Examples of the products offered are Varitect, Cytotect CP and Albiomin.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Neuro Ablation Devices Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2283/neuro-ablation-devices-market

Neuralgia Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2282/neuralgia-treatment-market

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com